Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
COSM Stock Forecast 2026-2027
$0.21
Current Price
$13.04M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to COSM Price Targets
+2,042.9%
To High Target of $4.50
+2,042.9%
To Median Target of $4.50
+2,042.9%
To Low Target of $4.50
COSM Price Momentum
-16.0%
1 Week Change
-32.3%
1 Month Change
-53.3%
1 Year Change
-58.0%
Year-to-Date Change
-84.1%
From 52W High of $1.32
+7.7%
From 52W Low of $0.19
📊 TOP ANALYST CALLS
Did COSM Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cosmos Holdings is one of their latest high-conviction picks.
Latest COSM Stock Price Targets & Analyst Predictions
COSM has shown a year-to-date change of -58.0% and a 1-year change of -53.3%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for COSM. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
COSM Analyst Ratings
0
Buy
0
Hold
0
Sell
COSM Price Target Range
Low
$4.50
Average
$4.50
High
$4.50
Current: $0.21
Latest COSM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for COSM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Cosmos Health Inc. (COSM) Competitors
The following stocks are similar to Cosmos Holdings based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
COSM
Cosmos Holdings
mkt cap
13.04M
Cosmos Health Inc. (COSM) Financial Data
Cosmos Health Inc. has a market capitalization of $13.04M with a P/E ratio of -0.3x. The company generates $69.49M in trailing twelve-month revenue with a -30.4% profit margin.
Revenue growth is +30.7% quarter-over-quarter, while maintaining an operating margin of -12.2% and return on equity of -92.3%.
Valuation Metrics
Market Cap
$13.04M
Enterprise Value
$29.27M
P/E Ratio
-0.3x
PEG Ratio
0.0x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
+30.7%
Gross Margin
+7.7%
Operating Margin
-12.2%
Net Margin
-30.4%
EPS Growth
+30.7%
Financial Health
Cash/Price Ratio
+4.8%
Current Ratio
1.1x
Debt/Equity
87.9x
ROE
-92.3%
ROA
-18.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cosmos Health Inc. (COSM) Business Model
About Cosmos Health Inc.
What They Do
Global healthcare group specializing in pharmaceuticals.
Business Model
The company operates a diversified business model that includes the importation, exportation, distribution, and sale of a wide range of healthcare products, including pharmaceuticals and nutraceuticals. It generates revenue through manufacturing proprietary brands, contract production, and offering telehealth services, while also managing a digital asset treasury to enhance its financial stability.
Additional Information
Founded in 2009 and headquartered in Thessaloniki, Greece, the company has a strong international presence with operations in Europe, the US, the UK, and the UAE. Cosmos Health Inc. is committed to innovation, evidenced by its research and development initiatives and the use of advanced technologies like robotic automation in its logistics operations.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
163
CEO
Mr. Grigorios Siokas
Country
Greece
IPO Year
2010
Website
www.cosmoshealthinc.comCosmos Health Inc. (COSM) Latest News & Analysis
Latest News
Quick Summary
FY2025 revenue reached a record $65.3M, with Q1 2026 showing strong performance. CosmoFarm and GMP-certified Cana achieved record operational volumes.
Why It Matters
Record revenue and operational momentum indicate strong growth and demand, potentially boosting investor confidence and driving stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Doc Pharma has a $24 million asset base, $6.7 million in average annual revenue, and $3.2 million in average annual gross profit, with expectations for margin expansion and improved cash flow.
Why It Matters
Doc Pharma's solid asset base and revenue indicate stability, while expected margin expansion and profitability suggest potential for increased returns and cash flow, attracting investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
C-Scrub and C-Sept have achieved over $1.5 million in combined annualized sales in the UK and Greece, indicating strong sales momentum in these markets.
Why It Matters
Strong sales in the UK and Greece signal robust demand for C-Scrub and C-Sept, highlighting market potential and likely positive revenue growth, which can boost investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Cosmos Health Inc. (NASDAQ:COSM) announced a three-year contract manufacturing agreement for its subsidiary Cana Laboratories with Verisfield S.A., a specialty pharmaceutical company.
Why It Matters
Cosmos Health's new contract with Verisfield enhances revenue stability and growth potential, signaling confidence in its manufacturing capabilities and strengthening its market position.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Cosmos Health Inc. (NASDAQ:COSM) announced its subsidiary, Cana Laboratories, secured contract manufacturing orders for 253,657 units of various pharmaceutical products from Nassington and Verisfield.
Why It Matters
Cosmos Health's new manufacturing contracts indicate revenue growth potential and increased demand for its products, enhancing investor confidence in the company's future performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Cosmos Health's subsidiary, Cana Laboratories, acquired an international patent for next-gen healthcare products, enhancing its IP portfolio and manufacturing capabilities in Europe.
Why It Matters
Cana Laboratories' acquisition of a key patent enhances Cosmos Health's IP portfolio and manufacturing capabilities, potentially boosting future revenue and shareholder value through innovative product development.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About COSM Stock
What is Cosmos Health Inc.'s (COSM) stock forecast for 2026?
Based on our analysis of 0 Wall Street analysts, Cosmos Health Inc. (COSM) has a median price target of $4.50. The highest price target is $4.50 and the lowest is $4.50.
Is COSM stock a good investment in 2026?
Analyst ratings for COSM are not currently available. The stock is currently trading at $0.21. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for COSM stock?
Wall Street analysts predict COSM stock could reach $4.50 in the next 12 months. This represents a 2,042.9% increase from the current price of $0.21. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cosmos Health Inc.'s business model?
The company operates a diversified business model that includes the importation, exportation, distribution, and sale of a wide range of healthcare products, including pharmaceuticals and nutraceuticals. It generates revenue through manufacturing proprietary brands, contract production, and offering telehealth services, while also managing a digital asset treasury to enhance its financial stability.
What is the highest forecasted price for COSM Cosmos Health Inc.?
The highest price target for COSM is $4.50 from at , which represents a 2,042.9% increase from the current price of $0.21.
What is the lowest forecasted price for COSM Cosmos Health Inc.?
The lowest price target for COSM is $4.50 from at , which represents a 2,042.9% increase from the current price of $0.21.
What is the overall COSM consensus from analysts for Cosmos Health Inc.?
Analyst ratings for COSM are not currently available. The stock is trading at $0.21.
How accurate are COSM stock price projections?
Stock price projections, including those for Cosmos Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 14, 2026 6:07 AM UTC